792411000001108: CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd) (product)

• SNOMED CT Concept\Pharmaceutical / biologic product\...
• \UK product\Actual medicinal product\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \UK product\Virtual medicinal product\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \UK product\Virtual therapeutic moiety\Irbesartan + Hydrochlorothiazide\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \UK product\Virtual therapeutic moiety\Irbesartan + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \UK product\Trade family\CoAprovel\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing angiotensin II receptor antagonist\Product containing irbesartan\Product containing irbesartan in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing angiotensin II receptor antagonist\Product containing irbesartan\Product containing hydrochlorothiazide and irbesartan\Irbesartan + Hydrochlorothiazide\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing angiotensin II receptor antagonist\Product containing irbesartan\Product containing hydrochlorothiazide and irbesartan\Irbesartan + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing angiotensin II receptor antagonist\Product containing irbesartan\Product containing hydrochlorothiazide and irbesartan\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing angiotensin II receptor antagonist\Product containing irbesartan\Product containing irbesartan in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing angiotensin II receptor antagonist\Product containing irbesartan\Product containing hydrochlorothiazide and irbesartan\Irbesartan + Hydrochlorothiazide\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing angiotensin II receptor antagonist\Product containing irbesartan\Product containing hydrochlorothiazide and irbesartan\Irbesartan + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing angiotensin II receptor antagonist\Product containing irbesartan\Product containing hydrochlorothiazide and irbesartan\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing irbesartan\Product containing irbesartan in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing irbesartan\Product containing hydrochlorothiazide and irbesartan\Irbesartan + Hydrochlorothiazide\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing irbesartan\Product containing hydrochlorothiazide and irbesartan\Irbesartan + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing irbesartan\Product containing hydrochlorothiazide and irbesartan\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and irbesartan\Irbesartan + Hydrochlorothiazide\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and irbesartan\Irbesartan + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and irbesartan\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and irbesartan\Irbesartan + Hydrochlorothiazide\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and irbesartan\Irbesartan + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and irbesartan\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and irbesartan\Irbesartan + Hydrochlorothiazide\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and irbesartan\Irbesartan + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and irbesartan\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Product manufactured as oral dose form\Product containing irbesartan in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)
• \Medicinal product\Product manufactured as oral dose form\Product containing hydrochlorothiazide in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
16853101000001116	CoAprovel 150mg/12.5mg tablets (Sanofi-Synthelabo Ltd) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
66033901000001114	CoAprovel 150mg/12.5mg tablets (Sanofi)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module

Expanded Value Set

This concept is not in any reference sets

Back to Start